Navigation Links
Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
Date:4/20/2011

hers’ regulations and reimbursement policies may affect the development, usage and pricing of our products.  Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.  We, or others, could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and product liability claims.  Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product.  Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers.  In addition, forward-looking statements about our 2011 guidance continue to be qualified by our prior statements that this guidance does not reflect any dramatic change in utilization for EPOGEN or Aranesp as a result of any major new regulatory or reimbursement changes.

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
2. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
3. Cepheid Reports 2011 First Quarter Results
4. ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011
5. Caliper Life Sciences First Quarter Results Conference Call Notice
6. Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use
7. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
8. PDL BioPharma to Announce First Quarter 2011 Financial Results on April 27, 2011
9. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
10. Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011
11. MiMedx Group, Inc. Announces Release Date for First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 31, 2015 The Allen Institute ... effort to define and advance the state-of-the-art digital ... launching today, called BigNeuron, aims to create reliable ... of branches that make up individual neurons: a ... encodes information. "In our quest ...
(Date:3/30/2015)... 2015 Shareholder rights attorneys at Robbins Arroyo ... Hyperion Therapeutics, Inc. (NASDAQ: HPTX ) by Horizon ... 2015, the two companies announced the signing of a ... Hyperion.  Under the terms of the agreement, Hyperion shareholders ... Hyperion common stock. View this information ...
(Date:3/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) will present ... 9:05 a.m. ET on Thursday, April 2, 2015, at the ... . Scott Foraker , vice president and general ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology:International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 2International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 4International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 5International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 6Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference 2
... Reportlinker.com announces that a new market research report ... Global Genetic Testing Industry ... markets for Genetic Testing in Millions of US$. The ... and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. ...
... 23, 2011 Reportlinker.com announces that a new ... Global Human Vaccines Industry ... This report analyzes the worldwide markets for Prophylatic ... segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. ...
Cached Medicine Technology:Reportlinker Adds Global Genetic Testing Industry 2Reportlinker Adds Global Human Vaccines Industry 2
(Date:3/31/2015)... Lake, Wis. (PRWEB) March 31, 2015 ... their patients and a faster return on their investment, ... body composition analyzer at Obesity Medicine 2015, April 8-12 ... for busy weight loss centers and medical offices, Rice ... as a health assessment tool. Obesity Medicine 2015 delivers ...
(Date:3/31/2015)... Como, Italy (PRWEB) March 31, 2015 A' ... design project Food Feeder Plus by Justin Cheung has been ... in Baby, Kids' and Children's Products Design Competition ... project leader of the awarded Baby Products project Food Feeder ... to eat alone, but also means more independence for the ...
(Date:3/31/2015)... San Francisco, CA (PRWEB) March 31, 2015 ... provider of Population Health and Analytics solutions, announces the ... Sales. Bedenbaugh will work with the Senior Vice President ... transform healthcare by empowering primary care providers to create ... in the Northeast including New York, New Jersey, Connecticut, ...
(Date:3/31/2015)... March 31, 2015 A' Design Award ... project Bruker EVOQ by Daniel Dion has been announced ... in Scientific Instruments, Medical Devices and Research Equipment ... Dion, the creative mind behind the award winning Medical ... - developed under the direction of Dr. Rohan Thakur ...
(Date:3/31/2015)... Austin, TX (PRWEB) March 31, 2015 Mega ... fun photo app in the market today. This free app ... transforming them into artistically creative, exciting, and fun masterpieces. Mega ... with including twisting, morphing, pinching, warping, and spinning images in ... the game changers for Mega Photo is that it has ...
Breaking Medicine News(10 mins):Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2Health News:Justin Cheung wins Golden in A' International Baby Products Design Awards 2Health News:i2i Systems Announces the Hire of Robert Bedenbaugh 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:New Mega Photo App Launched and Provides the Ultimate Playground for Photos 2
... Scientists have discovered the first evidence linking brain function ... brain to size at birth and the weight of ... the causes of mental health problems in later life. ... and the Medical Research Council (MRC) Lifecourse Epidemiology Unit ...
... is associated with negative outcomes for the mother, including increased ... length of stay in the hospital, and does not provide ... deliveries continues to climb, it is important for physicians and ... The new findings, published in the February issue of ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Doctors must not ... disorders who take antipsychotic drugs, experts warn. The authors of ... noted that patients with severe mental illness live an average ... disease, not suicide, is the major cause of death in these ...
... By Alan Mozes HealthDay Reporter , ... bike-only tracks that are physically separated from street traffic ... vehicles, a new study finds. "We found that ... bicycling on cycle tracks, compared with bicycling in parallel ...
... the basic functional concept is that synapses transmit electrical ... axons carry signals away (output). In one of many ... can operate in reverse: they can send signals to ... axons can talk to each other. Before sending signals ...
... Reinberg HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay News) ... the United States last fall, but is now circulating in all ... deaths from flu tripled in the past month, jumping from 10 ... U.S. Centers for Disease Control and Prevention. "We still have ...
Cached Medicine News:Health News:Brain function linked to birth size in groundbreaking new study 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 3Health News:Antipsychotic Drugs Raise Heart Risks, Experts Warn 2Health News:Separate Bikes-Only Lanes in Cities Cut Injury Rate: Study 2Health News:Separate Bikes-Only Lanes in Cities Cut Injury Rate: Study 3Health News:Rewrite the textbooks 2Health News:Rewrite the textbooks 3Health News:U.S. Flu Season Picking Up, CDC Reports 2
... an in-vitro diagnostic test kit for ... cruzi in human serum/plasma. This test ... using gelatin particles coated with inactivated ... particles are agglutinated in the presence ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
Inquire...
Silicone ICD lead...
Medicine Products: